You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. AUTOMATION OF BLOOD SMEAR PROCEDURE

    SBC: Aev Inc.            Topic: N/A

    THE PURPOSE OF THIS RESEARCH IS TO ESTABLISH THE FEASIBILITYOF UTILIZING COLOR COMPUTER VISION AND NEURAL NETWORK TECHNOLOGIES TO AUTOMATE THE WHITE CELL DIFFERENTIAL CURRENTLY PERFORMED BY MEDICAL TECHNOLOGISTS. AUTOMATION OF THE MICROSCOPIC BLOOD DIFFERENTIAL PROCEDURE IS NEEDED TOIMPROVE THE ACCURACY AND CONSISTENCY OF THIS IMPORTANT PROCEDURE IN THE DETECTION OF LEUKEMIA, INFECTION, AND OTHERD ...

    SBIR Phase II 1992 Department of Health and Human Services
  2. IMINOBIOTINYLATED DIDEOXYNUCLEOTODES FPR DNA SEQUENCING

    SBC: AMBION DIAGNOSTICS, INC.            Topic: N/A

    A VARIETY OF DIFFERENT APPROACHES ARE BEING TAKEN TO INCREASE THE SPED AND DECREASING THE SPEED AND DECREASE THE COST OF DNA SEQUENCING. ONE OF THE MAJOR CURRENT SEQUENCING TECHNOLOGIES IS THE DIDEOXYNUCLEOTIDE CHAIN-TERMINATING APPROACH ORIGINALLY DEVELOPED BY SANGER. WE WILL USE A VARIANT OF THIS APPROACH IN WHICH THE DIDEOXYNUCLEOTIDES WILL BE MODIFIED WITH AN IMINOBIOTIN GROUP. IMINOBIOTIN BIN ...

    SBIR Phase I 1992 Department of Health and Human Services
  3. TECHNOLOGY FOR DETECTION OF SINGLE BASE MUTATIONS

    SBC: AMBION DIAGNOSTICS, INC.            Topic: N/A

    N/A

    SBIR Phase I 1992 Department of Health and Human Services
  4. DEVELOPMENT OF AN ELECTROMECHANICAL TOTAL ARTIFICIAL HEART (TAH)

    SBC: American Biomed Inc            Topic: N/A

    AN ELECTROMECHANICALLY DRIVEN TOTALLY IMPLANTABLE TOTAL ARTIFICIAL HEART (TAH) WAS DEVELOPED RECENTLY AT BAYLOR COLLEGE OF MEDICINE. THIS EXPERIMENTAL PROTOTYPE WAS PROVED TO BE RELIABLE AND EFFECTIVE, YET SMALL ENOUGH TO IMPLANT INSIDE THE CHEST CAVITY OF AN AVERAGE HUMAN PATIENT. THIS TAH SYSTEM WAS ASSEMBLED BY SELECTING AND COMBINING THE BEST, SIMPLEST AND MOST RELIABLE FEATURES AVAILABLE FROM ...

    SBIR Phase I 1992 Department of Health and Human Services
  5. SOFTWARE FOR COMBINED MEG AND MAGNETIC RESONANCE IMAGING

    SBC: AMERINEX APPLIED IMAGING, INC.            Topic: N/A

    CLINICAL USE OF MAGNETOENCEPHALOGRAPHIC (MEG) DATA WILL DEPEND UPON A VARIETY OF FACTORS, ONE OF WHICH IS THE RAPID DISPLAY OF ELECTRICAL SOURCES THAT PRODUCE SIGNALS WITHIN THE BRAIN. CURRENTLY, SINGLE DIPOLE APPROXIMATIONS OF THE SOURCE LOCATION ARE OVERLAID ON TWO-DIMENSIONAL MAGNETIC RESONANCE IMAGES (MRI) FOR DISPLAY OF THE UNDERLYING ANATOMY. THIS PROCEDURE IS SLOW AND IS A CRUDE APPROXIMATI ...

    SBIR Phase I 1992 Department of Health and Human Services
  6. SEQUENCE ANALYSIS OF TK AND HPRT GENE MUTATIONS

    SBC: APPLIED GENETICS LABORATORIES            Topic: N/A

    N/A

    SBIR Phase I 1992 Department of Health and Human Services
  7. CORDLESS LIGHT PEN AND INTERFACE AUTHORING SYSTEM

    SBC: APPLIED HUMAN FACTORS INC            Topic: N/A

    N/A

    SBIR Phase I 1992 Department of Health and Human Services
  8. MULTIPLEXED RECEIVER COILS FOR MRI

    SBC: Applied Resonance Technology            Topic: N/A

    N/A

    SBIR Phase I 1992 Department of Health and Human Services
  9. FEASIBILITY OF PRECLINICAL SCALEUP OF LIPOSOMAL TNF

    SBC: Argus Pharmaceuticals Inc            Topic: N/A

    IN THIS PHASE I EFFORT, WE WILL DEMONSTRATE THE ABILITY TO SCALE UP THE PRODUCTION OF A LEAD LIPOSOMAL FORMULATION CANDIDATE OF ACYLATED, LIPOPHILIC RHUTNF. WE WILL SUBJECT THE BACTERIAL RECOMBINANT PROTEIN TO ACYLATION WITH THE N-HYDROXYSUCCUNIMIDE ESTER OF CAPRYLIC ACID (C3) TO ACHIEVE LIMITED SUBSTITUTION (1.5 TO 2 RESIDUES PER TNF TRIMER). THE IDENTITY AND EXTENT OF SUBSTITUTION OF THE TARGET ...

    SBIR Phase I 1992 Department of Health and Human Services
  10. DEVELOPMENT OF OPTIMUM CONDITIONS FOR NIMC PRODUCTION

    SBC: Argus Pharmaceuticals Inc            Topic: N/A

    MITOCHONDRIAL RESPIRATION INHIBITION IN TUMOR CELLS MAY OCCUR IN TWO MANNERS. ONE MECHANISM INVOLVES THE SYNTHESIS OF NITRIC OXIDE (NO) BY MACROPHAGES OR IFN-GAMMA MEDIATED INDUCTION OF NO SYNTHESIS IN TUMOR CELLS. WE HAVE RECENTLY ESTABLISHED A MURINE MACROPHAGE CELL LINE, EA13.5, THAT RELEASES A SOLUBLE MEDIATOR, NIMC, THAT CAUSES TUMOR CELL RESPIRATION INHIBITION INDEPENDENT OF NO PRODUCTION AN ...

    SBIR Phase I 1992 Department of Health and Human Services
US Flag An Official Website of the United States Government